Fresita Proteins
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Sarda Proteins Limited's board approved a rights issue of fully paid-up equity shares of face value ₹10 each to eligible shareholders for an amount not exceeding ₹100 crore. The company will file a draft letter of offer with SEBI and the stock exchanges and has constituted a rights issue committee to oversee the issue; the record date will be intimated separately. The board also approved the appointment of necessary intermediaries. It took note of the resignation of non-executive director Gunvantray Jayantilal Zaladi with effect from close of business on August 5, 2026.
Powered by Tijori
Sarda Proteins Limited's board approved a rights issue of fully paid-up equity shares of face value ₹10 each to eligible shareholders for an amount not exceeding ₹100 crore. The company will file a draft letter of offer with SEBI and the stock exchanges and has constituted a rights issue committee to oversee the issue; the record date will be intimated separately. The board also approved the appointment of necessary intermediaries. It took note of the resignation of non-executive director Gunvantray Jayantilal Zaladi with effect from close of business on August 5, 2026.
Powered by Tijori
Sarda Proteins Limited announced that its managing director, Chirag Thummar, resigned from the board on July 4, 2026, with the board immediately appointing Shirish Savaliya as the new managing director for a five-year term. The board also approved an increase in authorised equity share capital from ₹13 crore to ₹100 crore and altered the objects clause of the memorandum of association. In parallel, Yagnik Satasiya was moved from chief financial officer to the post of non-executive chairperson, and Drashti Delvadiya was named as the new CFO. Three other directors—Bipinkumar Savalia, Khilan Savaliya, and independent director Chintan Bhatt—also resigned effective immediately. These sweeping board and management changes come shortly after Onix Renewable Limited completed its open offer for a 19.28% stake in the company.
Powered by Tijori
Sarda Proteins Limited announced that its managing director, Chirag Thummar, resigned from the board on July 4, 2026, with the board immediately appointing Shirish Savaliya as the new managing director for a five-year term. The board also approved an increase in authorised equity share capital from ₹13 crore to ₹100 crore and altered the objects clause of the memorandum of association. In parallel, Yagnik Satasiya was moved from chief financial officer to the post of non-executive chairperson, and Drashti Delvadiya was named as the new CFO. Three other directors—Bipinkumar Savalia, Khilan Savaliya, and independent director Chintan Bhatt—also resigned effective immediately. These sweeping board and management changes come shortly after Onix Renewable Limited completed its open offer for a 19.28% stake in the company.
Powered by Tijori
Dec 24 (Reuters) - Sarda Proteins Ltd SARP.BO:
SARDA PROTEINS LTD -TO ISSUE 350,000 EQUITY SHARES
SARDA PROTEINS LTD -TO ISSUE OF 8.3 MILLION CONVERTIBLE WARRANTS
Source text: ID:nBSE6F2gbf
Further company coverage: SARP.BO
(([email protected];))
Dec 24 (Reuters) - Sarda Proteins Ltd SARP.BO:
SARDA PROTEINS LTD -TO ISSUE 350,000 EQUITY SHARES
SARDA PROTEINS LTD -TO ISSUE OF 8.3 MILLION CONVERTIBLE WARRANTS
Source text: ID:nBSE6F2gbf
Further company coverage: SARP.BO
(([email protected];))
Dec 18 (Reuters) - Sarda Proteins Ltd SARP.BO:
BOARD TO CONSIDER FUND RAISING ON DEC 24
Source text: ID:nBSEv6VsT
Further company coverage: SARP.BO
(([email protected];;))
Dec 18 (Reuters) - Sarda Proteins Ltd SARP.BO:
BOARD TO CONSIDER FUND RAISING ON DEC 24
Source text: ID:nBSEv6VsT
Further company coverage: SARP.BO
(([email protected];;))
Sept 4 (Reuters) - Sarda Proteins Ltd SARP.BO:
NAMES CHIRAG THUMAR AS MD
Source text for Eikon: ID:nBSE9D9dLs
Further company coverage: SARP.BO
(([email protected];;))
Sept 4 (Reuters) - Sarda Proteins Ltd SARP.BO:
NAMES CHIRAG THUMAR AS MD
Source text for Eikon: ID:nBSE9D9dLs
Further company coverage: SARP.BO
(([email protected];;))
July 15 (Reuters) - Sarda Proteins Ltd SARP.BO:
CFO SHIPRA GANDHI RESIGNS
Source text for Eikon: ID:nBSE2KcvmF
Further company coverage: SARP.BO
(([email protected];;))
July 15 (Reuters) - Sarda Proteins Ltd SARP.BO:
CFO SHIPRA GANDHI RESIGNS
Source text for Eikon: ID:nBSE2KcvmF
Further company coverage: SARP.BO
(([email protected];;))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Fresita Proteins do?
Sarda Proteins Ltd specializes in the manufacturing and marketing of mustard oil.
Who are the competitors of Fresita Proteins?
Fresita Proteins major competitors are Shri Gang Ind&Allied, Yashhtej Inds. (I), Ambar Protein Inds., MK Proteins, Raj Consumer Care, Diligent Industries, Ajanta Soya. Market Cap of Fresita Proteins is ₹117 Crs. While the median market cap of its peers are ₹114 Crs.
Is Fresita Proteins financially stable compared to its competitors?
Fresita Proteins seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Fresita Proteins pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Fresita Proteins latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Fresita Proteins allocated its funds?
Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances
How strong is Fresita Proteins balance sheet?
Balance sheet of Fresita Proteins is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Fresita Proteins improving?
The profit is oscillating. The profit of Fresita Proteins is ₹2.63 Crs for TTM, ₹0.01 Crs for Mar 2025 and ₹0.02 Crs for Mar 2024.
Is the debt of Fresita Proteins increasing or decreasing?
The net debt of Fresita Proteins is decreasing. Latest net debt of Fresita Proteins is -₹7.36 Crs as of Mar-26. This is less than Mar-25 when it was -₹0.07 Crs.
Is Fresita Proteins stock expensive?
Fresita Proteins is not expensive. Latest PE of Fresita Proteins is 44.45, while 3 year average PE is 79.29. Also latest EV/EBITDA of Fresita Proteins is 0.0 while 3yr average is 45.52.
Has the share price of Fresita Proteins grown faster than its competition?
Fresita Proteins has given better returns compared to its competitors. Fresita Proteins has grown at ~18.07% over the last 4yrs while peers have grown at a median rate of -19.0%
Is the promoter bullish about Fresita Proteins?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Fresita Proteins?
There is Insufficient data to gauge this.